An introduction to Peptide therapies: BPC-157

In this 162nd episode I begin to unpack the topic of peptides—what they are, how they work, and why tiny chains of amino acids are becoming major players in healing and recovery. In this particular episode I focus on BPC-157: a 15–amino‑acid fragment derived from human gastric juice that’s been studied since the 1990s for wound healing, tendon and ligament repair, gut protection, anti‑inflammatory effects, angiomodulation, and potential neuroprotection. I will walk through real‑world considerations: common administration routes (oral, subcutaneous, intramuscular, IV, topical), pros and cons of liposomal oral delivery, typical dosing examples (e.g., liposomal BPC-157 at 500 mcg twice daily), cycling strategies for long‑term use, time to effect, and typical cost ranges for peptide therapy. We also cover safety caveats—especially the theoretical cancer concern that warrants avoiding use with known malignancy. Finally, we compare related formulas (BPC blends with KPV or TB‑500) and practical tips for anyone curious about peptide therapy.Episode takeawaysWhat peptides are and why they act as cellular messengers.How BPC‑157 may speed healing and protect organs and the gut.Practical dosing, delivery options, cost realities, and safety considerations.How to evaluate formulations and when to seek medical oversight.Citations:A new gastric juice peptide, BPC. An overview of thestomach-stress-organoprotection hypothesis and beneficial effects of BPChttps://pubmed.ncbi.nlm.nih.gov/8298609/